Sales & Marketing News | pharmaphorum

News

J&J gets FDA okay for psoriasis drug icotrokinra

Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

News

First MHRA/NICE aligned guidance due in June

The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

News

US court says pharma giants must face False Claims suit

An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.

News

AZ piles pressure on MSD et al in gastric cancer

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

Ipsen appoints Michelle Werner as North America head

Ipsen has appointed biopharma industry veteran Michelle Werner, who recently stepped down as CEO of Alltrna, to lead its North America division.

J&J gets FDA okay for psoriasis drug icotrokinra

First MHRA/NICE aligned guidance due in June

US court says pharma giants must face False Claims suit

AZ piles pressure on MSD et al in gastric cancer

GSK's RSV shot cleared in US for all adults

Ipsen appoints Michelle Werner as North America head

Basecamp lifts veil on Trillion Gene Atlas genomics push

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks